AdaptHealthAHCO +1.56%71 EV-to-FCF is 17.84 as of Jul. 04, 2026, which is 6% below its 10-year median of 18.96. GuruFocus rates AHCO with a GF Score™ of 71/100 and a GF Value™ of $10.17 (Fairly Valued). The stock has 6 warning signs investors should review. Among 418 Medical Devices & Instruments companies, AdaptHealth ranks better than 62.68% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AdaptHealth's Enterprise Value is $3,424 Mil.
AdaptHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $192 Mil. Therefore, AdaptHealth's EV-to-FCF for today is 17.84.
The historical rank and industry rank for AdaptHealth's EV-to-FCF or its related term are showing as below:
AHCO'
s EV-to-FCF Range Over the Past 10 Years
Min: -308.1 Med: 18.96 Max: 289.93
Current: 17.84
During the past 9 years, the highest EV-to-FCF of AdaptHealth was 289.93. The lowest was -308.10. And the median was 18.96.
AHCO's EV-to-FCF is ranked better than 62.68% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs AHCO: 17.84
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AdaptHealth's PE Ratio (TTM) for today is calculated as:
AdaptHealth's share price for today is $10.76.
AdaptHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
AdaptHealth EV-to-FCF Related Terms
AdaptHealth EV-to-FCF Historical Data
* Premium members only.
The historical data trend for AdaptHealth's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AdaptHealth's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AdaptHealth EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where AdaptHealth's EV-to-FCF falls into.
AdaptHealth's current Enterprise Value is $3,424 Mil.
AdaptHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $192 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth (AHCO) has a EV-to-FCF of 17.84 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AdaptHealth and its competitors. This is near median its historical median of 18.96. According to the industry distribution chart, AdaptHealth ranks #156 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 37.3%.
Is AdaptHealth's EV-to-FCF too high?
AdaptHealth's current EV-to-FCF of 17.84 is near median its 10-year median of 18.96. The Medical Devices & Instruments industry median EV-to-FCF is 23.12. AdaptHealth's value of 17.84 is 22.8% below this industry median. Based on the distribution chart, AdaptHealth ranks #156 out of 418 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AdaptHealth has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AdaptHealth's EV-to-FCF compare to ATEC and IART?
According to the Medical Devices & Instruments industry distribution chart, AdaptHealth ranks #156 out of 418 companies for EV-to-FCF. This puts AdaptHealth in the upper half of its industry. The industry median EV-to-FCF is 23.12. AdaptHealth's value of 17.84 is 22.8% below this benchmark. While the company's 10-year median is 18.96 vs. the industry median of 23.12, AdaptHealth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AdaptHealth's current EV-to-FCF of 17.84 is 22.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AdaptHealth and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AdaptHealth's current EV-to-FCF is 17.84, which is near median its own 10-year median of 18.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdaptHealth stock overvalued right now?
Based on GuruFocus' analysis, AdaptHealth (AHCO) is currently considered Fairly Valued. The stock's GF Value™ is $10.17, compared to a current price of $10.76 — trading 5.8% above its estimated fair value. The current EV-to-FCF is 17.84, which is near median its 10-year median of 18.96 and 22.8% below the Medical Devices & Instruments industry median of 23.12. AdaptHealth's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For AdaptHealth (AHCO), the current EV-to-FCF is 17.84 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AdaptHealth (AHCO) Overvalued in 2026?
Based on GuruFocus' analysis, AdaptHealth stock appears to be overvalued.
The current stock price of $10.76 is trading 5.8% above its estimated GF Value™ of $10.17.
GuruFocus considers AdaptHealth to be Fairly Valued.
Key valuation signals for AHCO:
EV-to-FCF: 17.84 (near median its 10-year median of 18.96)
GF Value™: $10.17 vs. price of $10.76 (5.8% above fair value)
Industry Position: 22.8% below the Medical Devices & Instruments median (#156 of 418)
No single metric tells the full story. See the AHCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
71GF Score
Get the complete analysis for AHCO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHCO has been successfully added to your 
